Starting January 6, France will impose stricter regulations on the prescription of anti-epileptic medications, particularly those containing valproate. Evidence has emerged linking paternal use of these drugs to potential neurodevelopmental issues in children. Advocacy from affected individuals, notably Jean-Marc Laurent and Marine Martin, highlights the need for better awareness of these risks. The French drug safety agency will now require specialists to provide detailed information to male patients regarding potential risks to their offspring, marking a significant shift in prescription practices.